AMINOSYN-PF 7% Drug Patent Profile
Which patents cover Aminosyn-pf 7%, and what generic alternatives are available?
Aminosyn-pf 7% is a drug marketed by Otsuka Icu Medcl and is included in one NDA.
The generic ingredient in AMINOSYN-PF 7% is amino acids. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aminosyn-pf 7%
A generic version of AMINOSYN-PF 7% was approved as amino acids by B BRAUN on April 13th, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMINOSYN-PF 7%?
- What are the global sales for AMINOSYN-PF 7%?
- What is Average Wholesale Price for AMINOSYN-PF 7%?
Summary for AMINOSYN-PF 7%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | AMINOSYN-PF 7% at DailyMed |
Pharmacology for AMINOSYN-PF 7%
| Drug Class | Amino Acid |
US Patents and Regulatory Information for AMINOSYN-PF 7%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka Icu Medcl | AMINOSYN-PF 7% | amino acids | INJECTABLE;INJECTION | 019398-001 | Sep 6, 1985 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
